Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal transplantation patients-Reference-Cited by-同舟云学术

Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal transplantation patients

Published:2019-07-03 Issue:9 Volume:85 Page:1964-1973
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Anutrakulchai Sirirat¹^ORCID,Pongskul Cholatip¹,Kritmetapak Kittrawee¹^ORCID,Limwattananon Chulaporn²,Vannaprasaht Suda³

Affiliation:

1. Division of Nephrology, Department of Medicine, Faculty of MedicineKhon Kaen University Khon Kaen Thailand

2. Department of Clinical Pharmacy, Faculty of Pharmaceutical SciencesKhon Kaen University Thailand

3. Department of Pharmacology, Faculty of MedicineKhon Kaen University Khon Kaen Thailand

Funder

Khon Kaen University

National Science and Technology Development Agency

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13980

Reference29 articles.

1. A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients

2. Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus

3. Pharmacogenetics of Immunosuppressant Polymorphism of CYP3A5 in Renal Transplant Recipients

4. A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

5. Cyclosporine A- and Tacrolimus-Mediated Inhibition of CYP3A4 and CYP3A5 In Vitro

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15

2. Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients;ACS Pharmacology & Translational Science;2024-08-13

3. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data;The Pharmacogenomics Journal;2024-05-15

4. Association between CYP3A5 Gene Polymorphism and Post-Transplant Acute Immune Rejection in Renal Transplant Recipients Receiving Tacrolimus Therapy: A Correlation Study;Archivos Españoles de Urología;2024

5. CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study;2023-10-09